155 related articles for article (PubMed ID: 33528032)
21. The Utility of Preoperative Serum CA125 Combined with HE4 to Predict Lymph Node Metastasis in Endometrial Cancer.
Prueksaritanond N; Angsathapon S; Insin P
Gynecol Obstet Invest; 2023; 88(1):53-60. PubMed ID: 36596280
[TBL] [Abstract][Full Text] [Related]
22. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
Nyangoh-Timoh K; Bendifallah S; Dion L; Ouldamer L; Levêque J
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):277-286. PubMed ID: 32004789
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients.
Omer B; Genc S; Takmaz O; Dirican A; Kusku-Kiraz Z; Berkman S; Gurdol F
Tumour Biol; 2013 Oct; 34(5):2645-50. PubMed ID: 23640061
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic value of human epididymis protein 4 for endometrial cancer is moderate.
Liu J; Han L; Jiao Z
Sci Rep; 2021 Jan; 11(1):575. PubMed ID: 33436780
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer.
Wang Y; Han C; Teng F; Bai Z; Tian W; Xue F
Int J Gynaecol Obstet; 2017 Jan; 136(1):58-63. PubMed ID: 28099710
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels.
Ahmed AA; Abdou AM
Curr Probl Cancer; 2019 Oct; 43(5):450-460. PubMed ID: 30670303
[TBL] [Abstract][Full Text] [Related]
27. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer.
Shen Y; Li L
Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144
[TBL] [Abstract][Full Text] [Related]
28. Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: A meta-analysis.
Li J; Wang X; Qu W; Wang J; Jiang SW
Clin Chim Acta; 2019 Jan; 488():215-220. PubMed ID: 30414437
[TBL] [Abstract][Full Text] [Related]
29. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
[TBL] [Abstract][Full Text] [Related]
30. Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.
Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kinalski M; Terlikowski SJ
Adv Med Sci; 2016 Mar; 61(1):23-7. PubMed ID: 26344910
[TBL] [Abstract][Full Text] [Related]
31. Utility of Pelvic MRI and Tumor Markers HE4 and CA125 to Predict Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer.
Zamani N; Modares Gilani M; Zamani F; Zamani MH
J Family Reprod Health; 2015 Nov; 9(4):177-83. PubMed ID: 27047564
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma.
Saarelainen SK; Peltonen N; Lehtimäki T; Perheentupa A; Vuento MH; Mäenpää JU
Am J Obstet Gynecol; 2013 Aug; 209(2):142.e1-6. PubMed ID: 23583212
[TBL] [Abstract][Full Text] [Related]
33. Association of preoperative serum HE4 levels on the survival of patients with endometrial cancer.
Insin P; Yimyam Y; Prueksaritanond N
Arch Gynecol Obstet; 2021 Nov; 304(5):1335-1343. PubMed ID: 34109467
[TBL] [Abstract][Full Text] [Related]
34. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
Zanotti L; Bignotti E; Calza S; Bandiera E; Ruggeri G; Galli C; Tognon G; Ragnoli M; Romani C; Tassi RA; Caimi L; Odicino FE; Sartori E; Pecorelli S; Ravaggi A
Clin Chem Lab Med; 2012 Dec; 50(12):2189-98. PubMed ID: 23096757
[TBL] [Abstract][Full Text] [Related]
35. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.
Stiekema A; Lok C; Korse CM; van Driel WJ; van der Noort V; Kenter GG; Van de Vijver KK
Virchows Arch; 2017 Jun; 470(6):655-664. PubMed ID: 28401338
[TBL] [Abstract][Full Text] [Related]
36. Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features.
Barr CE; Njoku K; Jones ER; Crosbie EJ
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428894
[TBL] [Abstract][Full Text] [Related]
37. Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen section.
Sanjuán A; Cobo T; Pahisa J; Escaramís G; Ordi J; Ayuso JR; Garcia S; Hernández S; Torné A; Martínez Román S; Lejárcegui JA; Vanrell JA
Int J Gynecol Cancer; 2006; 16(1):385-90. PubMed ID: 16445663
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis.
Bie Y; Zhang Z
World J Surg Oncol; 2014 May; 12():169. PubMed ID: 24885319
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
Suri A; Perumal V; Ammalli P; Suryan V; Bansal SK
Sci Rep; 2021 Aug; 11(1):17308. PubMed ID: 34453074
[TBL] [Abstract][Full Text] [Related]
40. The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas.
Simmons AR; Baggerly K; Bast RC
Oncology (Williston Park); 2013 Jun; 27(6):548-56. PubMed ID: 23909069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]